Physician

Amy D. Lazar, M.D.

According to 2025 Medicare claims, Amy Lazar, M.D. (NPI: 1568441988) practices otolaryngology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Somerset, NJ. This provider's primary affiliated billing organization is ENT AND ALLERGY ASSOCIATES LLP (NPI: 1376598326; TIN: 134000192) and primary practice location at 08807-2560.

Lazar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 636 traditional Medicare patients, billed 3,410 HCPCS/CPT codes, and received $215,918 in Medicare payments. The top billing code was 31231 (Diagnostic exam of nasal passages using an endoscope). Part D data shows 1,057 prescription claims across 389 beneficiaries totaling $27,754 in drug costs, led by Ipratropium Bromide (Ipratropium Bromide). Open Payments data shows 31 records totaling $585. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $66,085 to $27,754. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	673	2,547	$217,471
2016	651	2,411	$192,332
2017	646	2,470	$190,057
2018	616	2,406	$188,023
2019	609	2,324	$186,135
2020	544	2,049	$174,760
2021	627	2,338	$226,377
2022	573	2,115	$213,242
2023	608	2,160	$208,734
2024	636	3,410	$215,918

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	282	845	$66,085
2016	308	918	$55,418
2017	334	989	$50,256
2018	341	1,062	$50,469
2019	372	1,079	$46,177
2020	338	1,045	$45,135
2021	366	1,038	$41,014
2022	370	1,151	$43,828
2023	381	1,075	$36,527
2024	389	1,057	$27,754

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
31231	Diagnostic exam of nasal passages using an endoscope	290	376	$164
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	229	229	$144
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	417	639	$115
G0268	Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing	218	238	$40
69210	Removal of impacted ear wax	231	307	$35

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ipratropium Bromide	Ipratropium Bromide	143	4,145	$4,893
Azelastine Hcl	Azelastine Hcl	123	5,095	$3,990
Azelastine-Fluticasone	Azelastine/Fluticasone	21	1,140	$3,666
Fluticasone Propionate	Fluticasone Propionate	152	8,695	$2,233
Mometasone Furoate	Mometasone Furoate	14	780	$1,463

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	31	$585	AERIN MEDICAL INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amy D. Lazar, M.D.?

Tedicare shows public-source Medicare data for Amy D. Lazar, M.D. (NPI 1568441988), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amy D. Lazar, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amy D. Lazar, M.D.?

Amy D. Lazar, M.D. is linked to ENT AND ALLERGY ASSOCIATES LLP (billing NPI 1376598326) in the available physician profile data.

Does Amy D. Lazar, M.D. have Open Payments data?

Amy D. Lazar, M.D. has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.